Retraction

MicroRNA-769-5p Inhibits Pancreatic Ductal Adenocarcinoma Progression by Directly Targeting and Downregulating ETS Proto-Oncogene 1

Citations (8)

8
Total Citations
2
Post-Retraction
(25.0%)
5
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
2 Within 1 year
0 After 2+ years
216 Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
The interaction between ETS transcription factor family members and microRNAs: A novel approach to cancer therapy
Liwei Du, Yuchen Liu, Chenxi Li et al. (5 authors)
Biomedicine & Pharmacotherapy Open Access
Published: May 2022
8 citations
216 days after retraction
Robust Validation and Comprehensive Analysis of a Novel Signature Derived from Crucial Metabolic Pathways of Pancreatic Ductal Adenocarcinoma
Wenchao Gu, Shaocong Mo, Yulin Wang et al. (10 authors)
Cancers Open Access
Published: Apr 2022
3 citations
185 days after retraction
Prognostic factors in adult brainstem glioma: a tertiary care center analysis and review of the literature
Annette Leibetseder, J. Leitner, Maximilian J. Mair et al. (14 authors)
Journal of Neurology Open Access
Published: Aug 2021
20 citations
59 days before retraction
TPX2 Enhanced the Activation of the HGF/ETS-1 Pathway and Increased the Invasion of Endocrine-Independent Prostate Carcinoma Cells
Hongqing Zhou, Liu Ming-sheng, Tao Shao et al. (9 authors)
Frontiers in Oncology Open Access
Published: May 2021
6 citations
126 days before retraction
Keratin 80 regulated by miR-206/ETS1 promotes tumor progression via the MEK/ERK pathway in ovarian cancer
Ouxuan Liu, Caixia Wang, Shuang Wang et al. (9 authors)
Journal of Cancer Open Access
Published: Jan 2021
21 citations
273 days before retraction
Systematic evaluation, verification and comparison of tuberculosis‐related non‐coding RNA diagnostic panels
Mengyuan Lyu, Yuhui Cheng, Jian Zhou et al. (7 authors)
Journal of Cellular and Molecular Medicine Open Access
Published: Dec 2020
8 citations
292 days before retraction
MicroRNAs in cancer therapy: Their involvement in oxaliplatin sensitivity/resistance of cancer cells with a focus on colorectal cancer
Milad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi et al. (7 authors)
Life Sciences
Published: Jun 2020
30 citations
468 days before retraction
Quick Stats
Total Citations: 13
Years Since Retraction: 4.1 years
Open Access: Yes
Last Checked: Jul 24, 2025
Related Papers